Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 398.27 Million

CAGR (2025-2030)

5.18%

Fastest Growing Segment

Monensin

Largest Market

North America

Market Size (2030)

USD 539.23 Million

Market Overview

The Global Feed Anticoccidial Market, valued at USD 398.27 Million in 2024, is projected to experience a CAGR of 5.18% to reach USD 539.23 Million by 2030. The Global Feed Anticoccidial Market centers on specialized pharmaceutical additives incorporated into animal feed, primarily for poultry and livestock, to prevent and control coccidiosis, a parasitic disease caused by *Eimeria* species that significantly impairs animal health and production efficiency. The market's expansion is driven by the increasing global demand for animal protein, particularly poultry, which necessitates robust disease prevention strategies to maintain livestock health and productivity. Furthermore, the persistent threat of coccidiosis-induced economic losses in animal agriculture consistently underpins the demand for these preventative solutions. According to the International Feed Industry Federation (IFIF), global commercial feed manufacturing generated an estimated annual turnover exceeding US $400 billion in 2023.

A significant challenge impeding market expansion is the continuous emergence of *Eimeria* parasite resistance to existing anticoccidial compounds, necessitating ongoing research and development for novel solutions and alternative control strategies.

Key Market Drivers

The Global Feed Anticoccidial Market is significantly influenced by the rising global demand for animal protein. As the human population and dietary preferences grow, the need for efficiently produced meat, dairy, and eggs intensifies. This pressures livestock producers to maximize animal health and productivity, increasing reliance on feed additives that prevent diseases. According to the Food and Agriculture Organization (FAO), in November 2024, "Food Outlook" forecast global meat production to reach 373 million tonnes in 2024, a 1.4% increase from 2023, primarily driven by poultry and bovine meat. Such growth necessitates robust disease control, fueling demand for effective anticoccidial solutions.

The substantial economic impact of coccidiosis on livestock production represents a critical market driver. This pervasive parasitic disease inflicts considerable financial losses on animal agriculture through impaired feed efficiency, reduced weight gain, and increased mortality rates. Mitigating these widespread economic detriments compels producers to implement comprehensive disease prevention and control programs, inherently including feed anticoccidials. According to Alltech's article "New challenges in coccidiosis control," published in August 2023, coccidiosis has been estimated to cause economic losses exceeding $3 billion globally. These significant losses underscore the sustained investment in solutions for livestock health. Reflecting this, according to Merck Animal Health, in May 2025, the company announced an $895 million investment in expanding its manufacturing and research and development facilities in De Soto, Kansas, specifically targeting global drug discovery and development for novel parasiticides and therapeutics. Such efforts highlight the ongoing need for advanced interventions to safeguard animal protein supply chains.


Download Free Sample Report

Key Market Challenges

The continuous emergence of *Eimeria* parasite resistance to existing anticoccidial compounds presents a substantial impediment to the growth of the Global Feed Anticoccidial Market. This resistance reduces the efficacy of established feed additives, compelling livestock and poultry producers to seek alternative and often more costly prevention strategies. The diminished effectiveness of conventional treatments directly curtails demand for these products, leading to a deceleration in sales volumes for established anticoccidial lines.

Consequently, market expansion is hampered by the need for continuous research and development into novel compounds, which entails significant investment and extended development timelines before new products can reach commercial viability. According to HealthforAnimals' Roadmap Progress Report 2023, the global Animal Health Sector invested an estimated $6.3 billion in Research and Development since November 2019, a considerable portion of which is dedicated to addressing persistent threats such as parasitic resistance. This ongoing requirement for substantial R&D expenditure to overcome resistance directly impacts manufacturers' profitability and market entry strategies for new products, thereby slowing the overall market's organic expansion.

Key Market Trends

The rising adoption of natural and herbal anticoccidial alternatives is a significant trend, propelled by consumer demand for antibiotic-free animal protein and efforts to combat antimicrobial resistance. This encourages botanicals, essential oils, and probiotics in animal feed. World Organisation for Animal Health (WOAH) data indicated a 5% global decrease in antimicrobial use, with a 53% reduction across 25 European countries between 2011 and 2022, highlighting this industry shift. Furthermore, ZIVO Bioscience and a global animal health company began a 42-day confirmatory study in July 2024 for a non-antibiotic, immune-modulating product for broiler coccidiosis, demonstrating increasing investment in sustainable control methods.

The expanding application of coccidiosis vaccines represents another crucial trend, shifting disease management towards proactive immunization instead of continuous in-feed medications. This strategy fosters natural immunity in poultry. The World Organisation for Animal Health (WOAH) "State of the World's Animal Health Report 2025" detailed 148.68 million poultry losses from 6,346 high pathogenicity avian influenza outbreaks between January 2024 and May 2025, underscoring the critical need for effective poultry health strategies. Reflecting this direction, Boehringer Ingelheim launched Vaxxilive® Cocci 3 in January 2024, a poultry coccidiosis vaccine providing a biological alternative to traditional in-feed drugs and strengthening animal protein production systems through immunity.

Segmental Insights

In the Global Feed Anticoccidial Market, Monensin stands out as the fastest-growing segment, demonstrating significant market momentum due to its established efficacy and advantageous properties. This rapid expansion is primarily driven by Monensin's remarkable ability to control coccidiosis, a parasitic disease severely impacting animal intestinal health, particularly within the poultry industry. Extensive research and development efforts have consistently validated its effectiveness and safety, solidifying its reputation as a trusted choice among livestock producers and veterinarians. Furthermore, Monensin's cost-effectiveness makes it an economically viable solution, while its specific mode of action, which disrupts parasite energy metabolism, reduces the potential for resistance development, thereby ensuring sustained performance in disease management.

Regional Insights

North America leads the global feed anticoccidial market due to its advanced livestock production practices and the substantial demand for animal protein. The region demonstrates a strong focus on animal health management, driven by a well-established livestock industry, particularly in the poultry sector. Stringent animal feed safety regulations, overseen by bodies such as the U. S. Food and Drug Administration (FDA) and the Association of American Feed Control Officials (AAFCO), foster the adoption of effective anticoccidial solutions. Furthermore, continuous technological advancements and significant investments in research and development by key companies contribute to the availability and early adoption of innovative products, ensuring robust disease prevention and control measures.

Recent Developments

  • In May 2025, academic research involving Gyeongsang National University and Hoxbio introduced a novel approach to managing poultry coccidiosis. The study explored the anticoccidial properties of a multicomplex mineral-based diet in broilers infected with *Eimeria acervulina*. Findings indicated that this dietary supplementation significantly reduced fecal oocyst output and improved body weight gain in infected chickens, without negatively affecting intestinal lesion scores. This breakthrough research suggests that multicomplex minerals could serve as a promising new alternative for the prevention and control of coccidiosis, contributing to the development of innovative solutions in the global feed anticoccidial market.

  • In May 2025, a study published in *Discover Animals* evaluated a phytogenic additive combination (PBC) as an effective strategy against *Eimeria* spp. infections in broiler chickens. The PBC formulation, comprising free and fiber-coated essential oils, inulin, beta-glucans, and ascorbic acid, demonstrated notable improvements in body weight gain and feed intake in challenged birds, outperforming a salinomycin-treated group in certain metrics. Furthermore, the PBC enhanced intestinal morphology, suggesting improved gut health. This breakthrough research presents a viable alternative to traditional anticoccidial drugs, offering a new direction for sustainable coccidiosis control in the global feed anticoccidial market.

  • In January 2025, new research highlighted the effectiveness of a feed additive containing a blend of thymol and carvacrol for broilers challenged with coccidiosis. The study, published in eJournals, demonstrated that this phytogenic essential oil blend significantly improved broiler performance and gut health. Birds receiving the additive showed enhanced body weight gain and feed conversion ratios, alongside increased beneficial gut bacteria and reduced intestinal lesion scores. This breakthrough research provides valuable insights into natural alternatives for coccidiosis control, addressing growing demand for non-pharmaceutical solutions within the global feed anticoccidial market.

  • In December 2024, the U.S. Food and Drug Administration (FDA) granted approval for Coxidin 90, a generic monensin Type A medicated article sponsored by Huvepharma EOOD. This new product is designated for inclusion in poultry feed to assist in preventing coccidiosis in various poultry, including broiler chickens, laying hen replacement chickens, and layer breeder replacement chickens. Coxidin 90, an ionophore anticoccidial, contains 90.7 grams of monensin per pound and is supplied in 25 kg bags. This approval expands the range of available options for poultry producers managing coccidial infections, directly impacting the global feed anticoccidial market.

Key Market Players

  • Huvepharma NV
  • Elanco Animal Health Incorporated
  • Impextraco NV
  • Phibro Animal Health Corporation
  • Ceva Animal Health, LLC
  • Kemin Industries Inc.
  • Virbac Schweiz AG
  • Zoetis Services LLC
  • Bioproperties Pty Ltd
  • Zydus Animal Health and Investments Limited

By Type

By Livestock

By Form

By Source

By Region

  • Monensin
  • Lasalocid
  • Salinomycin
  • Nicarbazin
  • Diclazuril
  • Others
  • Poultry
  • Swine
  • Ruminant
  • Others
  • Dry
  • Liquid
  • Chemical
  • Natural
  • Report Scope:

    In this report, the Global Feed Anticoccidial Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

    • Feed Anticoccidial Market, By Type:
    • Feed Anticoccidial Market, By Livestock:

    o   Monensin

    o   Lasalocid

    o   Salinomycin

    o   Nicarbazin

    o   Diclazuril

    o   Others

    • Feed Anticoccidial Market, By Form:

    o   Poultry

    o   Swine

    o   Ruminant

    o   Others

    • Feed Anticoccidial Market, By Source:

    o   Dry

    o   Liquid

    • Feed Anticoccidial Market, By Region:

    o   Chemical

    o   Natural

    Competitive Landscape

    Company Profiles: Detailed analysis of the major companies presents in the Global Feed Anticoccidial Market.

    Available Customizations:

    Global Feed Anticoccidial Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).

    Global Feed Anticoccidial Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

    Table of content

    Table of content

    1.    Product Overview

    1.1.  Market Definition

    1.2.  Scope of the Market

    1.2.1.  Markets Covered

    1.2.2.  Years Considered for Study

    1.2.3.  Key Market Segmentations

    2.    Research Methodology

    2.1.  Objective of the Study

    2.2.  Baseline Methodology

    2.3.  Key Industry Partners

    2.4.  Major Association and Secondary Sources

    2.5.  Forecasting Methodology

    2.6.  Data Triangulation & Validation

    2.7.  Assumptions and Limitations

    3.    Executive Summary

    3.1.  Overview of the Market

    3.2.  Overview of Key Market Segmentations

    3.3.  Overview of Key Market Players

    3.4.  Overview of Key Regions/Countries

    3.5.  Overview of Market Drivers, Challenges, Trends

    4.    Voice of Customer

    5.    Global Feed Anticoccidial Market Outlook

    5.1.  Market Size & Forecast

    5.1.1.  By Value

    5.2.  Market Share & Forecast

    5.2.1.  By Type (Monensin, Lasalocid, Salinomycin, Nicarbazin, Diclazuril, Others)

    5.2.2.  By Livestock (Poultry, Swine, Ruminant, Others)

    5.2.3.  By Form (Dry, Liquid)

    5.2.4.  By Source (Chemical, Natural)

    5.2.5.  By Region

    5.2.6.  By Company (2024)

    5.3.  Market Map

    6.    North America Feed Anticoccidial Market Outlook

    6.1.  Market Size & Forecast

    6.1.1.  By Value

    6.2.  Market Share & Forecast

    6.2.1.  By Type

    6.2.2.  By Livestock

    6.2.3.  By Form

    6.2.4.  By Source

    6.2.5.  By Country

    6.3.    North America: Country Analysis

    6.3.1.    United States Feed Anticoccidial Market Outlook

    6.3.1.1.  Market Size & Forecast

    6.3.1.1.1.  By Value

    6.3.1.2.  Market Share & Forecast

    6.3.1.2.1.  By Type

    6.3.1.2.2.  By Livestock

    6.3.1.2.3.  By Form

    6.3.1.2.4.  By Source

    6.3.2.    Canada Feed Anticoccidial Market Outlook

    6.3.2.1.  Market Size & Forecast

    6.3.2.1.1.  By Value

    6.3.2.2.  Market Share & Forecast

    6.3.2.2.1.  By Type

    6.3.2.2.2.  By Livestock

    6.3.2.2.3.  By Form

    6.3.2.2.4.  By Source

    6.3.3.    Mexico Feed Anticoccidial Market Outlook

    6.3.3.1.  Market Size & Forecast

    6.3.3.1.1.  By Value

    6.3.3.2.  Market Share & Forecast

    6.3.3.2.1.  By Type

    6.3.3.2.2.  By Livestock

    6.3.3.2.3.  By Form

    6.3.3.2.4.  By Source

    7.    Europe Feed Anticoccidial Market Outlook

    7.1.  Market Size & Forecast

    7.1.1.  By Value

    7.2.  Market Share & Forecast

    7.2.1.  By Type

    7.2.2.  By Livestock

    7.2.3.  By Form

    7.2.4.  By Source

    7.2.5.  By Country

    7.3.    Europe: Country Analysis

    7.3.1.    Germany Feed Anticoccidial Market Outlook

    7.3.1.1.  Market Size & Forecast

    7.3.1.1.1.  By Value

    7.3.1.2.  Market Share & Forecast

    7.3.1.2.1.  By Type

    7.3.1.2.2.  By Livestock

    7.3.1.2.3.  By Form

    7.3.1.2.4.  By Source

    7.3.2.    France Feed Anticoccidial Market Outlook

    7.3.2.1.  Market Size & Forecast

    7.3.2.1.1.  By Value

    7.3.2.2.  Market Share & Forecast

    7.3.2.2.1.  By Type

    7.3.2.2.2.  By Livestock

    7.3.2.2.3.  By Form

    7.3.2.2.4.  By Source

    7.3.3.    United Kingdom Feed Anticoccidial Market Outlook

    7.3.3.1.  Market Size & Forecast

    7.3.3.1.1.  By Value

    7.3.3.2.  Market Share & Forecast

    7.3.3.2.1.  By Type

    7.3.3.2.2.  By Livestock

    7.3.3.2.3.  By Form

    7.3.3.2.4.  By Source

    7.3.4.    Italy Feed Anticoccidial Market Outlook

    7.3.4.1.  Market Size & Forecast

    7.3.4.1.1.  By Value

    7.3.4.2.  Market Share & Forecast

    7.3.4.2.1.  By Type

    7.3.4.2.2.  By Livestock

    7.3.4.2.3.  By Form

    7.3.4.2.4.  By Source

    7.3.5.    Spain Feed Anticoccidial Market Outlook

    7.3.5.1.  Market Size & Forecast

    7.3.5.1.1.  By Value

    7.3.5.2.  Market Share & Forecast

    7.3.5.2.1.  By Type

    7.3.5.2.2.  By Livestock

    7.3.5.2.3.  By Form

    7.3.5.2.4.  By Source

    8.    Asia Pacific Feed Anticoccidial Market Outlook

    8.1.  Market Size & Forecast

    8.1.1.  By Value

    8.2.  Market Share & Forecast

    8.2.1.  By Type

    8.2.2.  By Livestock

    8.2.3.  By Form

    8.2.4.  By Source

    8.2.5.  By Country

    8.3.    Asia Pacific: Country Analysis

    8.3.1.    China Feed Anticoccidial Market Outlook

    8.3.1.1.  Market Size & Forecast

    8.3.1.1.1.  By Value

    8.3.1.2.  Market Share & Forecast

    8.3.1.2.1.  By Type

    8.3.1.2.2.  By Livestock

    8.3.1.2.3.  By Form

    8.3.1.2.4.  By Source

    8.3.2.    India Feed Anticoccidial Market Outlook

    8.3.2.1.  Market Size & Forecast

    8.3.2.1.1.  By Value

    8.3.2.2.  Market Share & Forecast

    8.3.2.2.1.  By Type

    8.3.2.2.2.  By Livestock

    8.3.2.2.3.  By Form

    8.3.2.2.4.  By Source

    8.3.3.    Japan Feed Anticoccidial Market Outlook

    8.3.3.1.  Market Size & Forecast

    8.3.3.1.1.  By Value

    8.3.3.2.  Market Share & Forecast

    8.3.3.2.1.  By Type

    8.3.3.2.2.  By Livestock

    8.3.3.2.3.  By Form

    8.3.3.2.4.  By Source

    8.3.4.    South Korea Feed Anticoccidial Market Outlook

    8.3.4.1.  Market Size & Forecast

    8.3.4.1.1.  By Value

    8.3.4.2.  Market Share & Forecast

    8.3.4.2.1.  By Type

    8.3.4.2.2.  By Livestock

    8.3.4.2.3.  By Form

    8.3.4.2.4.  By Source

    8.3.5.    Australia Feed Anticoccidial Market Outlook

    8.3.5.1.  Market Size & Forecast

    8.3.5.1.1.  By Value

    8.3.5.2.  Market Share & Forecast

    8.3.5.2.1.  By Type

    8.3.5.2.2.  By Livestock

    8.3.5.2.3.  By Form

    8.3.5.2.4.  By Source

    9.    Middle East & Africa Feed Anticoccidial Market Outlook

    9.1.  Market Size & Forecast

    9.1.1.  By Value

    9.2.  Market Share & Forecast

    9.2.1.  By Type

    9.2.2.  By Livestock

    9.2.3.  By Form

    9.2.4.  By Source

    9.2.5.  By Country

    9.3.    Middle East & Africa: Country Analysis

    9.3.1.    Saudi Arabia Feed Anticoccidial Market Outlook

    9.3.1.1.  Market Size & Forecast

    9.3.1.1.1.  By Value

    9.3.1.2.  Market Share & Forecast

    9.3.1.2.1.  By Type

    9.3.1.2.2.  By Livestock

    9.3.1.2.3.  By Form

    9.3.1.2.4.  By Source

    9.3.2.    UAE Feed Anticoccidial Market Outlook

    9.3.2.1.  Market Size & Forecast

    9.3.2.1.1.  By Value

    9.3.2.2.  Market Share & Forecast

    9.3.2.2.1.  By Type

    9.3.2.2.2.  By Livestock

    9.3.2.2.3.  By Form

    9.3.2.2.4.  By Source

    9.3.3.    South Africa Feed Anticoccidial Market Outlook

    9.3.3.1.  Market Size & Forecast

    9.3.3.1.1.  By Value

    9.3.3.2.  Market Share & Forecast

    9.3.3.2.1.  By Type

    9.3.3.2.2.  By Livestock

    9.3.3.2.3.  By Form

    9.3.3.2.4.  By Source

    10.    South America Feed Anticoccidial Market Outlook

    10.1.  Market Size & Forecast

    10.1.1.  By Value

    10.2.  Market Share & Forecast

    10.2.1.  By Type

    10.2.2.  By Livestock

    10.2.3.  By Form

    10.2.4.  By Source

    10.2.5.  By Country

    10.3.    South America: Country Analysis

    10.3.1.    Brazil Feed Anticoccidial Market Outlook

    10.3.1.1.  Market Size & Forecast

    10.3.1.1.1.  By Value

    10.3.1.2.  Market Share & Forecast

    10.3.1.2.1.  By Type

    10.3.1.2.2.  By Livestock

    10.3.1.2.3.  By Form

    10.3.1.2.4.  By Source

    10.3.2.    Colombia Feed Anticoccidial Market Outlook

    10.3.2.1.  Market Size & Forecast

    10.3.2.1.1.  By Value

    10.3.2.2.  Market Share & Forecast

    10.3.2.2.1.  By Type

    10.3.2.2.2.  By Livestock

    10.3.2.2.3.  By Form

    10.3.2.2.4.  By Source

    10.3.3.    Argentina Feed Anticoccidial Market Outlook

    10.3.3.1.  Market Size & Forecast

    10.3.3.1.1.  By Value

    10.3.3.2.  Market Share & Forecast

    10.3.3.2.1.  By Type

    10.3.3.2.2.  By Livestock

    10.3.3.2.3.  By Form

    10.3.3.2.4.  By Source

    11.    Market Dynamics

    11.1.  Drivers

    11.2.  Challenges

    12.    Market Trends & Developments

    12.1.  Merger & Acquisition (If Any)

    12.2.  Product Launches (If Any)

    12.3.  Recent Developments

    13.    Global Feed Anticoccidial Market: SWOT Analysis

    14.    Porter's Five Forces Analysis

    14.1.  Competition in the Industry

    14.2.  Potential of New Entrants

    14.3.  Power of Suppliers

    14.4.  Power of Customers

    14.5.  Threat of Substitute Products

    15.    Competitive Landscape

    15.1.  Huvepharma NV

    15.1.1.  Business Overview

    15.1.2.  Products & Services

    15.1.3.  Recent Developments

    15.1.4.  Key Personnel

    15.1.5.  SWOT Analysis

    15.2.  Elanco Animal Health Incorporated

    15.3.  Impextraco NV

    15.4.  Phibro Animal Health Corporation

    15.5.  Ceva Animal Health, LLC

    15.6.  Kemin Industries Inc.

    15.7.  Virbac Schweiz AG

    15.8.  Zoetis Services LLC

    15.9.  Bioproperties Pty Ltd

    15.10.  Zydus Animal Health and Investments Limited

    16.    Strategic Recommendations

    17.    About Us & Disclaimer

    Figures and Tables

    Frequently asked questions

    Frequently asked questions

    The market size of the Global Feed Anticoccidial Market was estimated to be USD 398.27 Million in 2024.

    North America is the dominating region in the Global Feed Anticoccidial Market.

    Monensin segment is the fastest growing segment in the Global Feed Anticoccidial Market.

    The Global Feed Anticoccidial Market is expected to grow at 5.18% between 2025 to 2030.

    Related Reports

    We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.